| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ORIGINAL RESEARCH COMMUNICATION |
1 From the Jean Mayer US Department of Agriculture Human Nutrition Research Center on Aging at Tufts University Boston MA (JS C-QL JM JMOKLT)the Bouvé College of Health Sciences at Northeastern University Boston MA (KLT).
2 Supported by the National Institutes of Health, National Institute on Aging grant 01AG023394-02 and National Heart, Lung, and Blood Institute grant HL54776; and the US Department of Agriculture, Agricultural Research Service contracts 53-K06-5-10 and 58-1950-9-001. 3 Address correspondence to J Shen, Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, 711 Washington Street, Boston, MA 02111-1524. E-mail: jian.shen{at}tufts.edu.
Background: Low vitamin B-6 status has been linked to an increased risk of cardiovascular diseases. The cardioprotective effects of vitamin B-6 independent of homocysteine suggest that additional mechanisms may be involved.
Objective: Our objective was to examine the cross-sectional association of vitamin B-6 status with markers of inflammation and oxidative stress.
Design: We measured plasma pyridoxal-5'-phosphate (PLP), C-reactive protein (CRP), and an oxidative DNA damage marker, urinary 8-hydroxydeoxyguanosine (8-OHdG), in Puerto Rican adults who were living in Massachusetts (n = 1205, aged 45–75 y).
Results: There was a strong dose-response relation of plasma PLP concentration with plasma CRP. Increasing quartiles of PLP were significantly associated with lower CRP concentrations (geometric means: 4.7, 3.6, 3.1, and 2.5 mg/L; P for trend < 0.0001) and with lower urinary 8-OHdG concentrations (geometric means: 124, 124, 117, and 108 ng/mg creatinine; P for trend: 0.025) after multivariate adjustment. These negative associations persisted after plasma homocysteine was controlled for. Plasma PLP concentrations were significantly correlated with plasma fasting glucose (r = –0.1, P = 0.0006), glycated hemoglobin (r = –0.08, P = 0.006), and homeostasis model assessment of β cell function (r = 0.082, P = 0.005). Metabolic syndrome, obesity, and diabetes were also significantly associated with low plasma PLP concentrations (P = 0.011, 0.0007, and 0.004, respectively).
Conclusions: Low vitamin B-6 concentrations are associated with inflammation, higher oxidative stress, and metabolic conditions in older Puerto Rican adults. Our data suggest that vitamin B-6 may influence cardiovascular disease risk through mechanisms other than homocysteine and support the notion that nutritional status may influence the health disparities present in this population.
This article has been cited by other articles:
![]() |
C. Q. Lai, L. D. Parnell, A. M. Troen, J. Shen, H. Caouette, D. Warodomwichit, Y. C. Lee, J. W. Crott, W. Q. Qiu, I. H. Rosenberg, et al. MAT1A variants are associated with hypertension, stroke, and markers of DNA damage and are modulated by plasma vitamin B-6 and folate Am. J. Clinical Nutrition, May 1, 2010; 91(5): 1377 - 1386. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Larsson, N. Orsini, and A. Wolk Vitamin B6 and Risk of Colorectal Cancer: A Meta-analysis of Prospective Studies JAMA, March 17, 2010; 303(11): 1077 - 1083. [Abstract] [Full Text] [PDF] |
||||